Dallas, TX 8/17/2009 11:01:24 PM
MFLI, OPSY, BLKL, IOVE, BPAX, GETA, August 17 Daily Market Movers Digest Report from OTCPicks.com
OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community. Our Stocks to Watch today include Muscle Flex Inc. (OTC: MFLI), Optical Systems Inc. (OTC: OPSY), Blink Logic Inc. (OTCBB: BLKL), The Italian Oven Inc. (OTC: IOVE), BioSante Pharmaceuticals Inc. (Nasdaq: BPAX) and Genta Inc. (OTCBB: GETA). For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/microcap.htm MUSCLE FLEX INCORPORATED (OTC: MFLI) "Up 21.95% in morning trading" Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast. OPTICAL SYSTEMS INCORPORATED (OTC: OPSY) Company Profile: http://www.otcpicks.com/optical-systems/optical-systems.htm Optical Systems, Inc., through its operating subsidiary, Automotive Software Designers, Inc., develops technology and services for the automotive retail industry designed to maximize productivity and increase profits at auto dealerships. ASDI's flagship technology solution, Save-a-Deal, is a turnkey customer relationship management (CRM) tool for auto dealerships. Our business development center (BDC) provides a variety of services designed to help auto dealerships drive traffic to their showroom or Web site, retain customers and generate new streams of revenue. BLINK LOGIC INCORPORATED (OTCBB: BLKL) "Up 311.76% in morning trading" Blink Logic Inc. partners with ISVs to deliver SaaS Business Intelligence (BI) solutions to business executives in companies of all sizes. With the Blink Logic platform, ISVs can enhance their customer offerings to include powerful, yet easy-to-understand, reporting and analytics. Executives can leverage a full range of BI capabilities and actionable information to enable them to make better, faster, more informed decisions, in order to continuously increase revenue, customer satisfaction and profitability. Blink Logic is provided as a secure internet-based solution. By sharing the software, hardware, maintenance and support costs across tens of thousands of customers, Blink Logic delivers tremendous capability to its partners and their customers at a low monthly subscription price. ITALIAN OVEN INCORPORATED (OTC: IOVE) "Up 41.38% in morning trading" In February 1997, The Italian Oven, Inc. completed the sale of substantially all of its assets to the Italian Oven LLC, an affiliate of the Whitecliff Group, Inc., in connection with its filing for voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code. Following the sale, The Italian Oven changed its name to Store Liquidation Company, Inc. Previously, The Italian Oven was engaged in the owning, operating, and franchising of Italian-style family-oriented casual dining restaurants in 16 states in the mid-Atlantic, midwest, southeast, and southwest regions of the United States; and in Australia. BIOSANTE PHARMACEUTICALS INCORPORATED (NASDAQ: BPAX) "Up 12.76% in morning trading" BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. BioSante's lead products include LibiGel® (transdermal testosterone gel) in Phase III clinical development by BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment) for the treatment of female sexual dysfunction (FSD), and Elestrin™ (estradiol gel) developed through FDA approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, currently marketed in the U.S. Also in development are Bio-T-Gel™, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate technology (CaP) for novel vaccines, drug delivery and aesthetic medicine (BioLook™). Additional information is available online at www.biosantepharma.com. GENTA INCORPORATED (OTCBB: GETA) "Up 6.41% in morning trading" Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. The leading drug in Genta’s Small Molecule program is Ganite® (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, which has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a “named-patient” basis in countries outside the United States. About OTCPicks.com OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com. Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. Disclosure: OTCPicks.com has been compensated three thousand five hundred dollars from Dana Alex for MFLI advertising and promotional services. OTCPicks.com has been compensated one hundred thousand free trading shares by a third party for OPSY advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by the company for BLKL advertising and promotional services. OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
